ABOUT MSD BALLYDINE
MSD Ballydine develops and supplies the active ingredients and final formulated product for a range of innovative medicines at its manufacturing and R&D facilities. The plant, which has been operating in Tipperary for over 40 years, exports to over 25 countries around the world with primary markets being Europe, USA and Japan.
Our highly-skilled local workforce of 500 employees is now leading the way in the development of new medicines, including MSD’s new treatment for hepatitis C, which is being manufactured in Tipperary for patients around the world.
